News Category: Health & Medical

–United States-based National Comprehensive Cancer Network enters strategic cooperation agreement with Chinese medical information website to publish and translate evidence-based expert consensus guidelines for cancer care; now available at nccnchina.org.cn ( https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=1106361729&u=http%3A%2F%2Fwww.nccnchina.org.cn&a=nccnchina.org.cn ). The National Comprehensive Cancer Network(R) (NCCN ( https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=769424173&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN )(R))-an alliance of leading cancer centers ( https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=3644457603&u=https%3A%2F%2Fwww.nccn.org%2Fhome%2Fmember-institutions&a=leading+cancer+centers ) in the United States-is announcing … Continued

Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced that the European Commission (EC) has granted orphan medicinal product designation for selinexor for the treatment of myelofibrosis (MF). Selinexor was granted orphan drug designation in MF by the … Continued

– Lo.Li. Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners. Pervistop[R] promises to be an extremely effective tool in the management of an exceedingly unpredictable disease. Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling … Continued

EpiVax, Inc. (“EpiVax”) is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine epitope selection portion of the collaboration using their comprehensive in silico vaccine design toolkit “iVAX” ( https://c212.net/c/link/?t=0&l=en&o=3692683-1&h=2887996362&u=https%3A%2F%2Fepivax.com%2Fimmunogenicity-assessment%2Fivax-web-based-vaccine-design&a=their+comprehensive+in+silico+vaccine+design+toolkit+%22iVAX%22 ). … Continued

Taimei Technology, a digital operation platform for the life science industry, announced that it has recently received the TRUSTe Enterprise Privacy Certification from TrustArc, a global leader in privacy solutions. The certification is a testament to Taimei’s internationally leading technology and management capability in privacy protection that provides their customers with security and peace of … Continued

Indonesian Health Minister Budi Gunadi Sadikin closed G20 Second Health Ministerial Meeting in Bali, 28 October 2022. This meeting is the culmination of G20 discussions about strengthening the global health architecture and strengthening pandemic prevention, preparedness and response. While current geopolitical tension had been widely reflected over the three days’ meetings, G20 member states maintain … Continued

World Psoriasis Day is October 29th. Each year, the global psoriatic disease community unites for action to raise awareness of psoriatic disease. This year’s theme is mental health. 1 in 10 people with psoriatic disease is diagnosed with clinical depression.[1] As many as 48% experience anxiety.[2] The psychological impact is increasingly recognized as a significant … Continued

On World Stroke Day (29th Oct), the World Stroke Organization has announced the launch of a new program that aims to drive access to quality acute stroke care and save lives around the world. Logo – https://mma.prnewswire.com/media/1929364/World_Stroke_Day_Campaign_Logo.jpg The WSO Stroke Certification initiative is a strategic response to the results of a WHO-WSO survey which found … Continued

— Marketing authorisation in the European Economic Area anticipated in H1 2023 Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation Application (MAA) for leniolisib has been validated for scientific evaluation under an accelerated assessment by the European Medicines Agency’s (EMA) Committee for Medicinal Products … Continued